COVID-19 vaccines not tied to immune-mediated neurological events
Mar 21, 2022
But increased risks for Bell palsy, encephalomyelitis and Guillain-Barré syndrome were observed following SARS-CoV-2 infection.
US to release flu meds from national stockpile to ease shortages
Dec 21, 2022
The decision comes as the nation suffers from an unusually early and hard flu season, with about 9,300 deaths so far.
Atrial fibrillation may increase risk for dementia
Mar 10, 2023
The risk was more prominent in younger patients and those without chronic kidney disease.
Ability to smell may be predictive marker of frailty
Feb 01, 2023
Both olfactory identification and sensitivity functions are associated with frailty.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
COVID-19 risk for dialysis patients tied to antibody response to vaccine
Aug 16, 2022
During omicron, the risk for a SARS-CoV-2 infection is dependent on the antibody response to the COVID-19 vaccine regardless of the number of doses.
Residual risk seen for death, postacute sequelae in third year after COVID-19 hospitalization
Jun 13, 2024
The risk for death remains significantly elevated in the third year, as is risk for incident postacute sequelae of COVID-19.
Influenza A(H3N2) predominant strain during 2021 to 2022 season
Jul 25, 2022
Two peaks were observed during 2021 to 2022 season, the first in mid-December 2021 and the second in mid-March to May 2022.
Systemic side effects of COVID-19 vaccine tied to greater nAB response
Jun 11, 2024
Each 1-degree Celsius increase in skin temperature after a dose was linked to a 1.8- and 3.1-fold higher neutralizing antibody response one and six months later.
Symptom presentation varies by SARS-CoV-2 variant
Dec 21, 2021
During the first wave of COVID-19, cough occurred first in the United States, whereas fever occurred first in China.